Free Trial

FOXO Technologies Q4 2023 Earnings Report

FOXO Technologies logo
$0.12 -0.01 (-6.35%)
Closing price 04:10 PM Eastern
Extended Trading
$0.12 0.00 (0.00%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FOXO Technologies EPS Results

Actual EPS
-$0.24
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

FOXO Technologies Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

FOXO Technologies Announcement Details

Quarter
Q4 2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

FOXO Technologies' Q4 2024 earnings is scheduled for Wednesday, June 4, 2025

Remove Ads

Earnings Documents

FOXO Technologies Earnings Headlines

New “Trump” currency proposed in DC
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
See More FOXO Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like FOXO Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on FOXO Technologies and other key companies, straight to your email.

About FOXO Technologies

FOXO Technologies (NYSEAMERICAN:FOXO) engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.

View FOXO Technologies Profile

More Earnings Resources from MarketBeat